Products

SurveyMonkey is built to handle every use case and need. Explore our product to learn how SurveyMonkey can work for you.

Get data-driven insights from a global leader in online surveys.

Explore core features and advanced tools in one powerful platform.

Build and customise online forms to collect info and payments.

Integrate with 100+ apps and plug-ins to get more done.

Purpose-built solutions for all of your market research needs.

Create better surveys and spot insights quickly with built-in AI.

Templates

Measure customer satisfaction and loyalty for your business.

Learn what makes customers happy and turn them into advocates.

Get actionable insights to improve the user experience.

Collect contact information from prospects, invitees, and more.

Easily collect and track RSVPs for your next event.

Find out what attendees want so that you can improve your next event.

Uncover insights to boost engagement and drive better results.

Get feedback from your attendees so you can run better meetings.

Use peer feedback to help improve employee performance.

Create better courses and improve teaching methods.

Learn how students rate the course material and its presentation.

Find out what your customers think about your new product ideas.

Resources

Best practices for using surveys and survey data

Our blog about surveys, tips for business, and more.

Tutorials and how to guides for using SurveyMonkey.

How top brands drive growth with SurveyMonkey.

Contact SalesLog in
Contact SalesLog in
COVID-19 and Reimagining Work

Outbreaks Near Me|SurveyMonkey Study: Booster Shot Eligibility

Outbreaks Near Me|SurveyMonkey Study: Booster Shot Eligibility

As booster shots become more widely available in the U.S., four in 10 vaccinated adults (41%) say they are currently eligible to receive a COVID-19 booster shot, 31% say they are not eligible, and 28% say they are “not sure,” according to new research from SurveyMonkey and Outbreaks Near Me, a team of researchers and epidemiologists at Boston Children’s Hospital. 

  • 72% of seniors age 65+ who have been vaccinated say they are currently eligible for a booster (15% say they are not; 13% are unsure)
  • 31% of adults age 18-64 who have been vaccinated say they are eligible for a booster (36% say they are not; 33% are unsure)
  • Uncertainty is higher for people of color: 25% of whites who are vaccinated say they are unsure whether they are eligible for the booster, compared with 31% of Blacks, 33% of Hispanics, 35% of Asians, and 30% of people of other races who have already been vaccinated
  • Republicans than Democrats who have been vaccinated say they are eligible for a booster at an equal rate (42%)
  • 47% of those who received the Pfizer vaccine say they are currently eligible for a booster, compared with 36% who received the Moderna vaccine and 27% who received the Johnson & Johnson vaccine
  • 52% of vaccinated healthcare workers say they are eligible for a booster, the highest of any industry

The new data, collected October 4-10 from a survey of 16,473 adults in the U.S., reveals the confusion surrounding the booster rollout. 

Among those who have been vaccinated, 65% say they would get a booster when it becomes available to them; just 6% say they would not, but 20% are unsure. 

  • People of all races, education levels, and genders are equally willing to get a booster shot when available
  • Just 55% of Republicans say they would get a booster once it’s available, compared with 60% of independents and 74% of Democrats
  • Pfizer vaccine recipients are most willing to get a booster (71%, vs. 62% among Moderna recipients and 60% among Johnson & Johnson recipients)
  • 32% of vaccinated 18-24 year olds are unsure if they will get a booster, the highest among any age group and over triple that of the oldest age group, those over 65 (10%)

Among those who are not willing or unsure whether they would get a booster shot, 28% say they are hesitant because “politics has played too much of a role in the vaccine development and recommendation process,” 25% are concerned about side effects, 23% say they have a lack of trust in the government, 22% say the recommendation is too new, and 22% say there are people who should be prioritized ahead of them.

Read more about our polling methodology here

Click through all the results in the interactive toplines below: